WT1 and cancer: Traditionally, anti-cancer vaccines have targeted tumor-associated antigens (TAAs), which are produced by genes overexpressed in cancer cells, such as Survivin (1), gp100 (2), WT1 (3), HER2/Neu (4) and MUC1 (5).